Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders

Heather K. Hughes, Emily Mills Ko, Destanie Rose, Paul Ashwood

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Autism spectrum disorders (ASD) are a group of heterogeneous neurological disorders that are highly variable and are clinically characterized by deficits in social interactions, communication, and stereotypical behaviors. Prevalence has risen from 1 in 10,000 in 1972 to 1 in 59 children in the United States in 2014. This rise in prevalence could be due in part to better diagnoses and awareness, however, these together cannot solely account for such a significant rise. While causative connections have not been proven in the majority of cases, many current studies focus on the combined effects of genetics and environment. Strikingly, a distinct picture of immune dysfunction has emerged and been supported by many independent studies over the past decade. Many players in the immune-ASD puzzle may be mechanistically contributing to pathogenesis of these disorders, including skewed cytokine responses, differences in total numbers and frequencies of immune cells and their subsets, neuroinflammation, and adaptive and innate immune dysfunction, as well as altered levels of immunoglobulin and the presence of autoantibodies which have been found in a substantial number of individuals with ASD. This review summarizes the latest research linking ASD, autoimmunity and immune dysfunction, and discusses evidence of a potential autoimmune component of ASD.

Original languageEnglish (US)
Article number405
JournalFrontiers in Cellular Neuroscience
Volume12
DOIs
StatePublished - Nov 13 2018

Fingerprint

Autoimmunity
Interpersonal Relations
Nervous System Diseases
Autoantibodies
Immunoglobulins
Communication
Autism Spectrum Disorder
Cytokines
Research

Keywords

  • Autism
  • Autoimmunity
  • Behavior
  • Dysregulation
  • Immune
  • Neurodevelopment

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders. / Hughes, Heather K.; Mills Ko, Emily; Rose, Destanie; Ashwood, Paul.

In: Frontiers in Cellular Neuroscience, Vol. 12, 405, 13.11.2018.

Research output: Contribution to journalReview article

@article{de51044734c34080ae4f4166a4903ab4,
title = "Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders",
abstract = "Autism spectrum disorders (ASD) are a group of heterogeneous neurological disorders that are highly variable and are clinically characterized by deficits in social interactions, communication, and stereotypical behaviors. Prevalence has risen from 1 in 10,000 in 1972 to 1 in 59 children in the United States in 2014. This rise in prevalence could be due in part to better diagnoses and awareness, however, these together cannot solely account for such a significant rise. While causative connections have not been proven in the majority of cases, many current studies focus on the combined effects of genetics and environment. Strikingly, a distinct picture of immune dysfunction has emerged and been supported by many independent studies over the past decade. Many players in the immune-ASD puzzle may be mechanistically contributing to pathogenesis of these disorders, including skewed cytokine responses, differences in total numbers and frequencies of immune cells and their subsets, neuroinflammation, and adaptive and innate immune dysfunction, as well as altered levels of immunoglobulin and the presence of autoantibodies which have been found in a substantial number of individuals with ASD. This review summarizes the latest research linking ASD, autoimmunity and immune dysfunction, and discusses evidence of a potential autoimmune component of ASD.",
keywords = "Autism, Autoimmunity, Behavior, Dysregulation, Immune, Neurodevelopment",
author = "Hughes, {Heather K.} and {Mills Ko}, Emily and Destanie Rose and Paul Ashwood",
year = "2018",
month = "11",
day = "13",
doi = "10.3389/fncel.2018.00405",
language = "English (US)",
volume = "12",
journal = "Frontiers in Cellular Neuroscience",
issn = "1662-5102",
publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders

AU - Hughes, Heather K.

AU - Mills Ko, Emily

AU - Rose, Destanie

AU - Ashwood, Paul

PY - 2018/11/13

Y1 - 2018/11/13

N2 - Autism spectrum disorders (ASD) are a group of heterogeneous neurological disorders that are highly variable and are clinically characterized by deficits in social interactions, communication, and stereotypical behaviors. Prevalence has risen from 1 in 10,000 in 1972 to 1 in 59 children in the United States in 2014. This rise in prevalence could be due in part to better diagnoses and awareness, however, these together cannot solely account for such a significant rise. While causative connections have not been proven in the majority of cases, many current studies focus on the combined effects of genetics and environment. Strikingly, a distinct picture of immune dysfunction has emerged and been supported by many independent studies over the past decade. Many players in the immune-ASD puzzle may be mechanistically contributing to pathogenesis of these disorders, including skewed cytokine responses, differences in total numbers and frequencies of immune cells and their subsets, neuroinflammation, and adaptive and innate immune dysfunction, as well as altered levels of immunoglobulin and the presence of autoantibodies which have been found in a substantial number of individuals with ASD. This review summarizes the latest research linking ASD, autoimmunity and immune dysfunction, and discusses evidence of a potential autoimmune component of ASD.

AB - Autism spectrum disorders (ASD) are a group of heterogeneous neurological disorders that are highly variable and are clinically characterized by deficits in social interactions, communication, and stereotypical behaviors. Prevalence has risen from 1 in 10,000 in 1972 to 1 in 59 children in the United States in 2014. This rise in prevalence could be due in part to better diagnoses and awareness, however, these together cannot solely account for such a significant rise. While causative connections have not been proven in the majority of cases, many current studies focus on the combined effects of genetics and environment. Strikingly, a distinct picture of immune dysfunction has emerged and been supported by many independent studies over the past decade. Many players in the immune-ASD puzzle may be mechanistically contributing to pathogenesis of these disorders, including skewed cytokine responses, differences in total numbers and frequencies of immune cells and their subsets, neuroinflammation, and adaptive and innate immune dysfunction, as well as altered levels of immunoglobulin and the presence of autoantibodies which have been found in a substantial number of individuals with ASD. This review summarizes the latest research linking ASD, autoimmunity and immune dysfunction, and discusses evidence of a potential autoimmune component of ASD.

KW - Autism

KW - Autoimmunity

KW - Behavior

KW - Dysregulation

KW - Immune

KW - Neurodevelopment

UR - http://www.scopus.com/inward/record.url?scp=85056859331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056859331&partnerID=8YFLogxK

U2 - 10.3389/fncel.2018.00405

DO - 10.3389/fncel.2018.00405

M3 - Review article

AN - SCOPUS:85056859331

VL - 12

JO - Frontiers in Cellular Neuroscience

JF - Frontiers in Cellular Neuroscience

SN - 1662-5102

M1 - 405

ER -